|
Physician was performing an implant, and he noted the dilator was difficult to pass through the 6f safesheath but managed with a little more force than usually required.When breaking at the hub, he noted it took a little more effort than used to.The introducer was removed and a new safesheath from a different lot was used instead.After the procedure the physician cracked the hub of the discarded sheath out of interest and noted it was difficult to split.It appears the issue was with peeling the introducer.No additional procedure details were provided.No adverse patient effects were reported.No medical or surgical intervention was reported.There was no report that the procedure was not successfully completed.No pictures or videos related to the malfunctioned device are available.
|
|
No product was returned to oscor inc.For evaluation and the device was discarded; however, a complaint notification was provided.Without the return of the actual device in question for evaluation, oscor inc.Is unable to determine the exact cause for this incident.Based on the information provided by the supporting documentation, the physician noted the dilator was difficult to pass through the 6f safesheath but managed with a little more force than usually required.After the procedure the physician cracked the hub of the discarded sheath out of interest and noted it was difficult to split.A review of the manufacturing processes indicates the production operators are instructed to 100% visually inspect for any obvious defect prior to shipment.At this time, it is not possible to assign a definitive root cause for the event as reported.The complaint is non-verifiable as the product was not returned for evaluation.The instructions for use (ifu) in forms the user: flush sheath with 5cc of saline immediately before peeling sheath away to minimize back bleeding.Withdraw sheath and valve over the lead or catheter and from the vessel, while keeping the lead in place.Sharply snap the tabs of valve housing in a plane perpendicular to the long axis of the sheath to split the valve and peel sheath apart while withdrawing from the vessel.No action required, the complaint is non-verifiable as the product was not returned for evaluation.The event will be re-evaluated if additional information becomes available.Oscor will continue to monitor this event type and risk.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
|